Furthermore, Kaplan–Meier survival analysis of TCGA and CGGA databases showed that patients with glioma and high expression level of PGK1 exhibited a conspicuously poor overall survival compared with patients with low PGK1 expression level (Figure 3F). This evidence concerns the gene PGK1 and central nervous system cancer.